comparemela.com

Latest Breaking News On - Institutional trading of arrowhead pharmaceuticals - Page 3 : comparemela.com

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Research Coverage Started at TD Cowen

TD Cowen assumed coverage on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Free Report) in a research report report published on Friday, Marketbeat Ratings reports. The firm issued an outperform rating on the biotechnology company’s stock. A number of other research firms also recently issued reports on ARWR. Sumitomo Mitsui Financial Group assumed coverage on shares […]

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Lowered to Market Perform at SVB Securities

SVB Securities downgraded shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Rating) from an outperform rating to a market perform rating in a report issued on Friday morning, The Fly reports. They currently have $40.00 target price on the biotechnology company’s stock. A number of other equities analysts also recently commented on the stock. B. Riley […]

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Downgraded by SVB Securities to Market Perform

SVB Securities cut shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Rating) from an outperform rating to a market perform rating in a research report released on Friday, The Fly reports. SVB Securities currently has $40.00 target price on the biotechnology company’s stock. A number of other equities research analysts also recently commented on the company. […]

Brokerages Set Arrowhead Pharmaceuticals, Inc (NASDAQ:ARWR) Target Price at $59 33

Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Rating) have been assigned an average recommendation of “Moderate Buy” from the fourteen brokerages that are covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating on the company. The average 12-month price […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.